@bk_laybourne's hormone therapy claims, fact-checked

What did @bk_laybourne actually say?

The creator describes a three-year hormone therapy journey prompted by her husband JT's post-cardiac-surgery recovery. She says her bloodwork showed she was "really, really, really low" in testosterone and had high estrogen. She also confirms she uses semaglutide, citing both aesthetic goals and a family history of diabetes as reasons. She recommends that everyone, regardless of gender, get their hormone levels checked if they're feeling fatigued or off.

To her credit, she's transparent about the semaglutide use after admitting she "really debated sharing this." She frames hormone therapy not as a quick fix but as a multi-year, clinically supervised process involving regular bloodwork. That's a more responsible framing than most wellness influencers manage. She does not name specific doses, brand names, or protocols, which keeps the content on the safer side of medical advice.

Does the science back this up?

Mostly, yes, with some important nuances. The claim that women can have low testosterone and that correcting it improves wellbeing has real support in the literature. The semaglutide rationale for prediabetes risk is also scientifically grounded, not just vanity-driven.

Testosterone in women is often overlooked clinically. A 2019 global consensus statement published in the Journal of Clinical Endocrinology and Metabolism (Davis et al., 2019) concluded that testosterone therapy in women is supported specifically for low sexual desire, but also noted broader effects on energy and mood. However, the evidence base for general "wellbeing" optimization in women without clear hypogonadism is thinner than many hormone clinics imply. Estrogen dominance as a discrete clinical diagnosis is contested, the term is used heavily in functional medicine but lacks standardized diagnostic criteria in conventional endocrinology. On semaglutide, the SUSTAIN and STEP trials (Marso et al., 2016, NEJM; Wilding et al., 2021, NEJM) showed meaningful cardiometabolic benefit beyond weight loss, including in people with prediabetes, so her doctor's rationale has real backing.

What did they get wrong (or right)?

She gets more right than wrong, but two things deserve scrutiny. First, the blanket "I would recommend hormone therapy to everyone" is sloppy and potentially harmful. Hormone therapy is not appropriate for everyone. People with certain hormone-sensitive cancers, cardiovascular risk factors, or blood clotting disorders face real contraindications. Endocrine Society guidelines are clear that testing and treatment should be individualized, not universally encouraged.

Second, she uses the phrase "D12" when likely referring to vitamin B12, which is not a hormone but a nutrient. Minor slip, but it muddles the clinical picture for viewers who might repeat this terminology to their own doctors. What she gets right is emphasizing bloodwork before treatment, working with a licensed provider, and not claiming the therapy alone caused her weight loss. She explicitly names semaglutide and the gym as co-contributors. That kind of honesty is rarer than it should be in this content space and deserves credit.

What should you actually know?

If you're considering hormone therapy because this video resonated with you, here's what actually matters clinically. Hormone testing is a legitimate starting point, but which tests, and how they're interpreted, varies significantly between conventional endocrinologists and functional medicine or aesthetics-focused clinics. Reference ranges used by wellness clinics are often different from those used in academic medicine, and "optimizing" levels within a normal range is not the same as treating a deficiency.

For semaglutide specifically, it is FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Off-label use for prediabetes or obesity prevention exists but should involve a real shared decision-making conversation, not just a wellness clinic recommendation. Compounded semaglutide, which many telehealth platforms and aesthetics clinics have been dispensing, is not equivalent to FDA-approved formulations and carries its own regulatory and quality considerations. The FDA issued warnings about this in 2023 and 2024. If you're being prescribed semaglutide through a clinic like the one described, ask specifically whether it is FDA-approved or compounded.

• Testosterone therapy in women has the strongest evidence for hypoactive sexual desire disorder, not general fatigue or "hormone optimization."
• "Estrogen dominance" is not a standardized diagnosis in conventional endocrinology.
• Semaglutide has legitimate cardiometabolic evidence beyond cosmetic weight loss.
• Hormone therapy carries real contraindications. "Everyone should get checked" is not the same as "everyone should treat."
• Always ask whether a prescribed medication is FDA-approved or compounded. They are not the same product.

Bottom line

This is a personal testimony, not a clinical recommendation, and the creator is reasonably careful to frame it that way. The core message, that unexplained fatigue and low mood in women can sometimes have a hormonal explanation worth investigating, is legitimate. The problem is the jump from "this worked for me" to "I would recommend this to everyone." That's where personal experience outpaces the evidence, and where viewers need to pump the brakes before booking an appointment at their nearest aesthetics clinic.